Li Lanjuan

This is an old revision of this page, as edited by Abductive (talk | contribs) at 05:30, 12 February 2020 (Epicenters are for earthquakes). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:Chinese name

Li Lanjuan
Li in 2006
Born (1947-09-13) 13 September 1947 (age 77)
Alma materZhejiang Medical University
SpouseZheng Shusen
Children1 son
AwardsState Science and Technology Progress Award (6 times)
Ho Leung Ho Lee Prize (2014)
Scientific career
FieldsEpidemiology
InstitutionsFirst Affiliated Hospital of Zhejiang University
Chinese name
Traditional Chinese
Simplified Chinese
Transcriptions
Standard Mandarin
Hanyu PinyinLǐ Lánjuān

Li Lanjuan (Chinese: 李兰娟; born 13 September 1947), also romanized as Lan-Juan Li, is a Chinese epidemiologist, hepatologist, and professor at Zhejiang University School of Medicine. She is an academician of the Chinese Academy of Engineering and serves as the director of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases. She developed Li-NBAL, an artificial liver support system that is widely used to sustain the lives of people suffering from acute liver failure, and won multiple national awards for her roles in combatting the SARS, H1N1, and H7N9 epidemics.

Early life and education

Li was born on 13 September 1947[1] into a poor peasant family in Shaoxing, Zhejiang. She excelled in her studies and tested into Hangzhou High School, a provincial key school.[2]

After graduation, she became a middle school substitute teacher in her township. She also studied acupuncture at Zhejiang Chinese Medicine Hospital and performed acupuncture for local elders. Her village later recommended her to become a barefoot doctor, and she accepted the offer despite it paying much less than her teaching job.[2] In 1970, when Chinese universities began admitting Worker-Peasant-Soldier students, Li was recommended by her township to study at Zhejiang Medical University (now Zhejiang University School of Medicine).[2]

Career

Upon graduation in 1973,[1] Li was assigned to work at the Department of Infectious Diseases at the First Affiliated Hospital of Zhejiang University [zh], commencing her career in epidemiology.[2] Acute liver failure caused by hepatitis B was very common in China. In 1986, Li and her team developed an artificial liver support system (ALSS), also called non-biological artificial liver (NBAL), to detoxify affected people and sustain their lives until the liver regenerates itself or a donor liver becomes available for transplant.[3] The system, now known as Li-NBAL,[3] has significantly improved survival rates for people with severe chronic hepatitis.[4] Instead of patenting the invention, she disseminated the technology to more than 300 hospitals all over China free of charge.[2]

She was appointed Vice President of the First Affiliated Hospital of Zhejiang University in October 1993, a position she held for three years. In November 1996 she became deputy director of the State Key Laboratory of Infectious Diseases of Ministry of Health, and was promoted to director six years later. She also served as Director of the Department of Health of the Zhejiang Provincial Government from 1998 to 2008.[1]

During the 2003 SARS outbreak, Li led the disease prevention effort in Zhejiang and effectively controlled the disease's spread in the province.[5] During the 2013 avian flu outbreak in the Yangtze Delta, Li's team quickly isolated the H7N9 strain as the pathogen and proved that the strain originated from live poultry markets. Her research prompted the government to quickly close all live poultry markets, preventing the spread of the disease to the rest of China.[5] For her contributions, she was awarded a Special Prize of the State Science and Technology Progress Award in 2017.[5]

During the 2019–20 Wuhan coronavirus outbreak, Li was the first to propose the lockdown of the center Wuhan; her proposal was adopted by the Chinese government, and the Wuhan lockdown was implemented on 23 January 2020.[2] On 1 February, she left for Wuhan with a team of medical workers from Hangzhou to help combat the epidemic.[6][7]

Honours and awards

  • 1998 State Science and Technology Progress Award (Second Class), for research on artificial liver support system[8]
  • 2005 elected as an academician of the Chinese Academy of Engineering (CAE)[1]
  • 2007 State Science and Technology Progress Award (Second Class), for research on the microecology of infectious diseases[8]
  • 2013 State Science and Technology Progress Award (First Class), for innovative theory and technological breakthrough in the treatment of severe liver disease[8]
  • 2014 State Science and Technology Progress Award (First Class), for research and effective prevention of the H1N1 flu pandemic in China[8]
  • 2014 Ho Leung Ho Lee Prize for Science and Technology Achievement[8]
  • 2015 State Science and Technology Progress Award (First Class), for innovative treatment of terminal liver disease[8]
  • 2017 State Science and Technology Progress Award (Special Prize), for major innovation and technological breakthrough in prevention systems of epidemics exemplified by the H7N9 avian flu[8]

Personal life

Li is married to Zheng Shusen, a liver transplant expert and also an academician of the Chinese Academy of Engineering.[9][10] The couple have a son named Zheng Jie (郑杰).[11]

See also

References

  1. ^ a b c d 李兰娟. Chinese Academy of Engineering. Retrieved 22 January 2020.{{cite web}}: CS1 maint: url-status (link)
  2. ^ a b c d e f 这位中国感染病学科唯一女院士 率先提出武汉封城. Sina News. 31 January 2020. Retrieved 2 February 2020.{{cite news}}: CS1 maint: url-status (link)
  3. ^ a b Ning, Qin (2019). Acute Exacerbation of Chronic Hepatitis B: Volume 2. Diagnosis and Management. Springer. p. 332. ISBN 978-94-024-1603-9.
  4. ^ Chang, Thomas Ming Swi; Endo, Yoshihiro; Nikolaev, Volodymyr (2017). Hemoperfusion, Plasmaperfusion And Other Clinical Uses Of General, Biospecific, Immuno And Leucocyte Adsorbents. World Scientific. p. 193. ISBN 978-981-4749-09-1.
  5. ^ a b c Fang Kun (方堃) (12 January 2018). 李兰娟院士团队荣获2017年度国家科技进步特等奖. China News (in Chinese). Retrieved 22 January 2020.
  6. ^ 李兰娟乔杰两位女院士带队出发驰援武汉. China Women's News. 2 February 2020. Retrieved 3 February 2020.{{cite web}}: CS1 maint: url-status (link)
  7. ^ 李兰娟院士带队驰援武汉:为抢救危重症病人,没考虑何时回来. The Paper. 1 February 2020. Retrieved 3 February 2020.{{cite web}}: CS1 maint: url-status (link)
  8. ^ a b c d e f g 科技奖项. Chinese Academy of Engineering. Retrieved 3 February 2020.{{cite web}}: CS1 maint: url-status (link)
  9. ^ Zhang Le (张乐) (26 May 2012). 郑树森李兰娟院士夫妇发起成立树兰基金. sciencenet.cn (in Chinese). Retrieved 22 January 2020.
  10. ^ Zhang Le (张乐); Wei Hui (韦慧) (23 May 2015). 李兰娟院士伉俪:无数次的风雨同舟才能相濡以沫. Xinhua (in Chinese). Retrieved 22 January 2020.
  11. ^ Zhang Zeqian (张泽茜) (2 February 2020). 儿子眼里的李兰娟院士:她一直都没有抛弃自己医生的身份. sina. Retrieved 3 February 2020.

Template:Members of the Chinese Academy of Engineering (2005)

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy